Absorbable permeability-modulated barrier composites and applications thereof
Absorbable barrier composites are designed for modulated gas and water permeability depending on clinical use and are formed of at least two physicochemically distinct components, one of which is a film adjoined to a knitted mesh and/or electrostatically spun, non-woven fabric. Depending on the physicochemical properties of the barrier composite, it can be used in neurological and urinogenital surgical procedures as well as tissue engineering and/or as physical barriers to prevent adhesion formation following several types of surgical procedures.
1. An absorbable, permeability-modulated barrier composite comprising, at least three physiocochemically distinct components;
a) a first component comprising a flexible film comprising a synthetic absorbable polymer of
i) a polyaxial copolyester derived from at least two monomers of glycolide, lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one or a morpholinedione;
ii) a polyether ester derived from a polyether-glycol that is grafted with at least one monomer of glycolide, lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one or a morpholinedione; or
iii) a polyether-ester-urethane derived from a polyether-glycol that is grafted with at least one monomer of glycolide, lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one or a morpholinedione, to form a polyether ester glycol, where the polyether ester glycol is interconnected by urethane linkages formed through the reaction of said polyether ester glycol with an aliphatic diisocyanate;
b) a second component comprising a knitted mesh comprising
i) an absorbable block copolymer comprising a block derived only from trimethylene carbonate and terminal segments derived from glycolide; or
ii) a warp-knitted construction comprising a polyaxial copolyester derived from at least two monomers selected from the group consisting of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, and a morpholinedione; and
c) a third component comprising an electrostatically spun, non-woven microfibrous fabric comprising,
i) a polyaxial copolyester derived from at least two monomers of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, or a morpholinedione; or
ii) a polyether-ester derived from a polyether-glycol grafted with at least one monomer of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, or a morpholinedione.
2. An absorbable, permeability-modulated barrier composite as in claim 1 , wherein the flexible film is adjoined directly to the knitted mesh, and the knitted mesh is adjoined directly to the microfibrous fabric, to form a layered composite.
3. An absorbable, permeability-modulated barrier composite as in claim 1 , wherein the flexible film is adjoined directly to the knitted mesh and the microfibrous fabric is adjoined directly to the knitted mesh, such that the flexible film and the microfibrous fabric are indirectly joined to each other with the knitted mesh sandwiched therebetween.
4. An absorbable, permeability-modulated barrier composite as in claim 1 , wherein at least one of the components comprises at least one bioactive agent, wherein the at least one bioactive agent comprises antimicrobial agents, anesthetic agents, anti-inflammatory agents, or tissue growth-promoting agents.
5. An absorbable, permeability-modulated barrier composite as in claim 1 , wherein at least one of the components comprises a hydroswellable polymer.
6. An absorbable, permeability-modulated barrier composite as in claim 1 , wherein the flexible film has a thickness of less than 500 microns.
7. An absorbable, permeability-modulated barrier composite as in claim 1 , wherein the flexible film has a thickness of less than 200 microns.
8. An absorbable, permeability-modulated barrier composite as in claim 1 , wherein the flexible film comprises the polyaxial copolyester derived from at least two monomers of glycolide, lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one or a morpholinedione according to romanett i); the knitted mesh comprises the warp-knitted construction comprising a polyaxial copolyester derived from at least two monomers selected from the group consisting of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, and a morpholinedione according to romanette ii); and the microfibrous fabric comprises the polyether-ester derived from a polyether-glycol grafted with at least one monomer of glycolide, l-lactide, ε-caprolactone, trimethylene carbonate, p-dioxanone, 1,5-dioxepan-2-one, or a morpholinedione according to romanette ii).
9. The barrier of claim 8 , wherein at least one of the components further comprises at least one bioactive agent.
10. A method of performing a spinal or cranial procedure in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 1 as a dura mater prosthesis in the spinal or cranial area of the subject.
11. A method of preventing surgical adhesions in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 1 in the area of the subject where the surgery was performed.
12. A method for repairing or replacing a portion of a urinary bladder of a vertebrate animal, the method comprising applying an absorbable, permeability-modulated barrier composite of claim 1 as a patch to the urinary bladder of the vertebrate animal.
13. A method for repairing or replacing a portion of a blood vessel of a vertebrate animal, the method comprising applying an absorbable, permeability-modulated barrier composite of claim 1 as a patch to the blood vessel of the vertebrate animal.
14. A method of performing a spinal or cranial procedure in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 8 as a dura mater prosthesis in the spinal or cranial area of the subject.
15. A method of preventing surgical adhesions in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 8 in the area of the subject where surgery was performed.
16. A method for repairing or replacing a portion of a urinary bladder of a vertebrate animal, the method comprising applying an absorbable, permeability-modulated barrier composite of claim 8 as a patch to the urinary bladder of the vertebrate animal.
17. A method for repairing or replacing a portion of a blood vessel of a vertebrate animal, the method comprising applying an absorbable, permeability-modulated barrier composite of claim 8 as a patch to the blood vessel of the vertebrate animal.
18. A method of performing a surgical procedure or reducing surgical adhesions in a subject in need thereof, the method comprising implanting an absorbable, permeability-modulated barrier composite of claim 9 in the area of the subject where the surgical procedure was performed.
19. A method for repairing or replacing a portion of a urinary bladder of a vertebrate animal, the method comprising applying an absorbable, permeability-modulated barrier composite of claim 9 as a patch to the urinary bladder of the vertebrate animal.
20. A method for repairing or replacing a portion of a blood vessel of a vertebrate animal, the method comprising applying an absorbable, permeability-modulated barrier composite of claim 9 as a patch to the blood vessel of the vertebrate animal.